![]() |
市场调查报告书
商品编码
1986459
消融设备市场报告:按设备技术、应用、最终用户和地区划分(2026-2034 年)Ablation Devices Market Report by Device Technology, Application, End User, and Region 2026-2034 |
||||||
2025年全球消融设备市场规模达71亿美元。展望未来,IMARC集团预测,到2034年,该市场规模将达到162亿美元,2026年至2034年的复合年增长率为9.32%。市场成长的主要驱动因素包括危及生命的疾病日益普遍、电生理技术在组织切除中的广泛应用,以及配备机器人导航系统的新一代消融设备的研发。
消融装置是一种医疗器械,用于各种医疗程序中,透过切除或破坏组织来治疗或控制某些疾病。这些装置的工作原理是利用热能、冷能或射频等能量照射目标组织,以达到切除或改变组织的目的。与传统外科手术相比,消融手术通常更受欢迎,因为它们创伤小、疼痛轻、恢復期短,且併发症风险较低。
受多种关键因素驱动,该市场正在成长,其中包括癌症、心房颤动和慢性静脉功能不全(CVI)等危及生命的疾病日益普遍。这些疾病发生率的上升凸显了对有效消融手术日益增长的需求。此外,大众对微创消融技术的认知度不断提高,也促进了市场扩张。这些手术具有许多优势,包括减轻疼痛、减少疤痕、降低不适感、缩短患者恢復时间。广泛采用电生理手术去除异常组织以治疗心律不整和心臟心律不整,也显着促进了市场成长。此外,製造商正积极回应不断变化的医疗需求,开发非热消融、非充气、非硬化性静脉消融装置,专门用于有效治疗浅层静脉逆流。
危及生命的疾病发生率正在上升。
癌症仍然是全球主要死因之一,近年来其发生率持续上升。消融手术作为一种微创手术治疗方法,尤其在肿瘤学领域,正日益受到关注。这些手术用于摧毁包括肝臟、肾臟和肺部在内的各种器官中的癌症组织。此外,慢性静脉功能不全(CVI)是一种腿部静脉无法将血液充分回流至心臟的疾病,会导致疼痛、肿胀和皮肤改变。目前,经静脉消融疗法(透过封闭功能异常的静脉)被广泛用于治疗CVI。 CVI的盛行率不断上升,这通常与生活方式和老龄化有关,也推动了对专为静脉治疗而设计的消融设备的需求。
电生理学的普及
电生理学是循环系统的一个分支,主要研究心臟的电活动。由于其在诊断和治疗包括心房颤动在内的各种心律不整方面的有效性,电生理学的应用正在迅速增长。电生理引导下的消融手术能够精准地辨识并消除心臟内异常电讯号的来源。这种方法已成为许多心律不整的标准治疗方法,能够有效缓解症状并提高患者的生活品质。此外,随着医疗专业人员对电生理引导下消融术益处的认识不断加深,其应用范围也不断扩大,对相关消融设备和器械的需求也日益增长。
下一代消融装置与机器人导航系统的集成
消融设备领域的技术进步是推动其发展的主要动力。新一代消融设备整合了机器人导航系统,显着提高了手术的准确性、精确性和疗效。机器人辅助消融能够达到更精准、更可控的组织消融,降低併发症风险,改善患者预后。这些机器人系统可提供治疗区域的即时成像和映射,使医护人员能够更自信地操控复杂的解剖结构。因此,这些先进消融设备的应用日益广泛,尤其是在那些致力于提供尖端治疗方案的医疗机构中。由于预期患者安全性和手术成功率的提升,对这些设备的需求也不断增长。
The global ablation devices market size reached USD 7.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.2 Billion by 2034, exhibiting a growth rate (CAGR) of 9.32% during 2026-2034. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
Radiofrequency devices represent the most used device technology
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer treatment holds the largest market share
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals accounts for majority of market share
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: